Director – GU Oncology & Phase I Clinical Trials: AdventHealth Cancer Institute
Guru has published and practiced extensively in the field of clinical oncology at multiple cancer institutes.
He has served as the principal investigator for several clinical trials, currently directs Advent's phase I program, and is extremely cognizant of the latest developments in the cancer therapeutics industry.
Physician Scientist, Medical Oncologist, Genomics Researcher: BWH, Dana-Farber, Broad Institute
Arvind has developed comprehensive expertise across quantitative, experimental, and clinical domains at the highest level of excellence.
This gives him the rare ability to not only see the whole picture but also zoom in wherever necessary.
His foundational research on the role of miRNA in oncogenesis and gene expression refined the known biological mechanisms of this omic.
Vice President – Data Strategy: Northwell Holdings
Marc has a proven track record of leading the development of enterprise data science initiatives in both clinical and digital health settings at companies such as Optum.
Now he is steering the strategy of New York's largest hospital system as they integrate machine learning into the clinic and build a data exchange platform for health networks.
When it comes to the biotech industry, Alex has seen it all.
He has managed legal, R&D, and commercial strategy at companies ranging from major pharmaceuticals, contract research organizations (CROs), and growth stage technology startups
– his accumen and innate ability to navigate challenging situations is unparalleled.